In type 2 diabetic patients, the insulinotropic response to a meal occurred within 30 minutes after an oral dose of repaglinide.
II tüüpi diabeedi haigetel kujunes insulinotroopne vastus toidule 30 min jooksul pärast repagliniidi suukaudset manustamist.